An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice

Author:

Wen Liang123,Xin Bing1ORCID,Wu Panyisha12,Lin Chia-Hao4,Peng Chuanhui13ORCID,Wang Gaowei1,Lee Jin1,Lu Li-Fan4,Feng Gen-Sheng1

Affiliation:

1. Department of Pathology, Division of Biological Sciences and Moores Cancer Center; University of California at San Diego; La Jolla CA

2. Department of General Surgery; Second Affiliated Hospital of Zhejiang University; Hangzhou P.R. China

3. Department of Surgery; First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou P.R. China

4. Division of Biological Sciences, Center for Microbiome Innovation and Moores Cancer Center; University of California at San Diego; La Jolla CA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2016

3. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer;J Hepatol,2012

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3